sequential cancer mutations cultured human intestinal stem cells
crypt stem cells represent cells origin intestinal neoplasia mouse human intestinal stem cells can cultured medium containing stem-cell-niche factors wnt r-spondin epidermal growth factor egf noggin long time periods epithelial organoids remain genetically phenotypically stable utilize crispr/cas9 technology targeted gene modification four commonly mutated colorectal cancer genes apc p53 also known tp53 kras smad4 cultured human intestinal stem cells mutant organoids can selected removing individual growth factors culture medium quadruple mutants grow independently stem-cell-niche factors tolerate presence p53 stabilizer nutlin- upon xenotransplantation mice quadruple mutants grow tumours features invasive carcinoma finally combined loss apc p53 sufficient appearance extensive aneuploidy hallmark tumour progression
